An assessment of CETP sequence variation in relation to cognitive decline and dementia risk

International Journal of Molecular Epidemiology and Genetics

Volumn 2, Issue 2, 2011, Pages 122-129

  Reynolds, Chandra A ^a   Gatz, Margaret ^b,c   Pedersen, Nancy L ^b,c   Prince, Jonathan A ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Alzheimer disease; CETP association; Cholesteryl ester transfer protein; Cognitive decline; Dementia

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN;

ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; FEMALE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79958125802     PISSN: None     EISSN: 19481756     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Schurmann B, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frolich L, Hampel H, Hull M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Muhleisen TW, Nothen MM, Moebus S, Jockel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Holmans PA, O'Donovan M, Owen MJ and Williams J. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 2009; 41: 1088-1093.
2. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B, Letenneur L, Bettens K, Berr C, Pasquier F, Fievet N, Barberger-Gateau P, Engelborghs S, De Deyn P, Mateo I, Franck A, Helisalmi S, Porcellini E, Hanon O, de Pancorbo MM, Lendon C, Dufouil C, Jaillard C, Leveillard T, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossu P, Piccardi P, Annoni G, Seripa D, Galimberti D, Hannequin D, Licastro F, Soininen H, Ritchie K, Blanche H, Dartigues JF, Tzourio C, Gut I, Van Broeckhoven C, Alperovitch A, Lathrop M and Amouyel P. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 2009; 41: 1094-1099.
3. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS and Roses AD. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 1993; 90: 1977-1981.
4. Payton A. The impact of genetic research on our understanding of normal cognitive ageing: 1995 to 2009. Neuropsychol Rev 2009; 19: 451-477.
5. Wisdom NM, Callahan JL and Hawkins KA. The effects of apolipoprotein E on non-impaired cognitive functioning: A meta-analysis. Neurobiol Aging 2009;
6. Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R, Heath SC, Timpson NJ, Najjar SS, Stringham HM, Strait J, Duren WL, Maschio A, Busonero F, Mulas A, Albai G, Swift AJ, Morken MA, Narisu N, Bennett D, Parish S, Shen H, Galan P, Meneton P, Hercberg S, Zelenika D, Chen WM, Li Y, Scott LJ, Scheet PA, Sundvall J, Watanabe RM, Nagaraja R, Ebrahim S, Lawlor DA, Ben-Shlomo Y, Davey-Smith G, Shuldiner AR, Collins R, Bergman RN, Uda M, Tuomilehto J, Cao A, Collins FS, Lakatta E, Lathrop GM, Boehnke M, Schlessinger D, Mohlke KL and Abecasis GR. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 2008; 40: 161-169.
7. Arias-Vasquez A, Isaacs A, Aulchenko YS, Hofman A, Oostra BA, Breteler M and van Duijn CM. The cholesteryl ester transfer protein (CETP) gene and the risk of Alzheimer's disease. Neurogenetics 2007; 8: 189-193.
8. Chen DW, Yang JF, Tang Z, Dong XM, Feng XL, Yu S and Chan P. Cholesteryl ester transfer protein polymorphism D442G associated with a potential decreased risk for Alzheimer's disease as a modifier for APOE epsilon4 in Chinese. Brain Res 2008; 1187: 52-57.
9. Qureischie H, Heun R, Popp J, Jessen F, Maier W, Schmitz S, Hentschel F, Kelemen P and Kolsch H. Association of CETP polymorphisms with the risk of vascular dementia and white matter lesions. J Neural Transm 2009; 116: 467-472.
10. Rodriguez E, Mateo I, Infante J, Llorca J, Berciano J and Combarros O. Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE epsilon4 allele. J Neurol 2006; 253: 181-185.
11. Sanders AE, Wang C, Katz M, Derby CA, Barzilai N, Ozelius L and Lipton RB. Association of a functional polymorphism in the cholesteryl ester transfer protein (CETP) gene with memory decline and incidence of dementia. JAMA 2010; 303: 150-158.
12. Lichtenstein P, De Faire U, Floderus B, Svartengren M, Svedberg P and Pedersen NL. The Swedish Twin Registry: a unique resource for clinical, epidemiological and genetic studies. J Intern Med 2002; 252: 184-205.
13. Reynolds CA, Hong MG, Eriksson UK, Blennow K, Bennet AM, Johansson B, Malmberg B, Berg S, Wiklund F, Gatz M, Pedersen NL and Prince JA. A survey of ABCA1 sequence variation confirms association with dementia. Hum Mutat 2009; 30: 1348-1354.
14. Finkel D and Pedersen NL. Processing speed and longitudinal trajectories of change for cognitive abilities: The Swedish Adoption/Twin Study of Aging. Aging, Neuropsychology, and Cognition Special Issue: Longitudinal studies of cognitive aging 2004; 11: 325-345.
15. Pedersen NL, Plomin R, Nesselroade JR and McClearn GE. A quantitative genetic analysis of cognitive abilities during the second half of the life span. Psychological Science 1992; 3: 346-353.
16. McClearn GE, Johansson B, Berg S, Pedersen NL, Ahern F, Petrill SA and Plomin R. Substantial genetic influence on cognitive abilities in twins 80 or more years old. Science 1997; 276: 1560-1563.
17. Gold CH, Malmberg B, McClearn GE, Pedersen NL and Berg S. Gender and health: a study of older unlike-sex twins. J Gerontol B Psychol Sci Soc Sci 2002; 57: S168-176.
18. Gatz M, Fratiglioni L, Johansson B, Berg S, Mortimer JA, Reynolds CA, Fiske A and Pedersen NL. Complete ascertainment of dementia in the Swedish Twin Registry: the HARMONY study. Neurobiol Aging 2005; 26: 439-447.
19. Reynolds CA, Finkel D, McArdle JJ, Gatz M, Berg S and Pedersen NL. Quantitative Genetic Analysis of Latent Growth Curve Models of Cognitive Abilities in Adulthood. Developmental Psychology 2005; 41: 3-16.
20. Carey V, Zeger S and Diggle P. Modeling multivariate binary data with alternating logistic regressions. Biometrika 1993; 80: 517-526.
21. Jansson M, Gatz M, Berg S, Johansson B, Malmberg B, McClearn GE, Schalling M and Pedersen NL. Association between depressed mood in the elderly and a 5-HTR2A gene variant. Am J Med Genet B Neuropsychiatr Genet 2003; 120B: 79-84.
22. Evans DA, Beckett LA, Field TS, Feng L, Albert MS, Bennett DA, Tycko B and Mayeux R. Apolipoprotein E epsilon4 and incidence of Alzheimer disease in a community population of older persons. JAMA 1997; 277: 822-824